Quantcast

Latest Venous thrombosis Stories

2014-07-30 12:30:01

Growth Will Be Driven Primarily By Adoption of Devices to Treat Stroke and Venous Thromboembolism, According to Findings from Decision Resources Group BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular embolectomy devices, designed for treating stroke patients, as well as...

2014-07-23 23:13:00

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) July 23, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A federal panel recently released updated records showing more than 8,500 cases still pending alleging side effects from the drugs*. DrugNews is a free online...

2014-07-23 12:31:37

However, Access Barriers Result in Greater Prescribing of Conventional Anticoagulants, According to Findings from Decision Resources Group BURLINGTON, Mass., July 23, 2014 /PRNewswire/ -- Decision Resources Group finds that novel oral anticoagulants (NOACs) such as Xarelto, Boehringer Ingelheim's Pradaxa and Bristol-Myers Squibb/Pfizer's Eliquis are preferred treatments for venous thromboembolism (VTE), atrial fibrillation (AF) and acute coronary syndrome (ACS) among physicians and payers in...

2014-07-17 23:01:02

The Firm is actively investigating potential claims on behalf of patients who allegedly suffered Xarelto internal bleeding, strokes, pulmonary embolism and/or deep vein thrombosis following use of the blood thinner. New York, NY (PRWEB) July 17, 2014 Bernstein Liebhard LLP has launched a new website for individuals who may be eligible to file a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) alleging injuries caused by the new-generation blood thinner, the Firm reports. The site...

2014-07-03 23:02:45

Zoll, Kranz & Borgess, LLC currently represents clients with injuries allegedly caused by testosterone therapy. Toledo, OH (PRWEB) July 03, 2014 The FDA is now requiring all testosterone replacement therapy products to have the general warning that these drugs may cause blood clots in the veins (Venous Thromboembolism (VTE)). Currently, the VTE warning is directly linked to polycythemia, which is when there is an increase in the number of red blood cells. Announced by the FDA June...

2014-07-03 20:21:28

At the California Institute for Deep Venous Thrombosis, Dr. Malekmehr and his team perform thrombolysis, mechanical thrombectomy and many other cutting-edge treatments for sufferers of DVT LOS ANGELES, July 3, 2014 /PRNewswire/ -- Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious - and even fatal - complications. Fortunately, at the California Institute for Deep Venous Thrombosis, those suffering from the...

2014-06-30 23:03:22

The conditions to fund the $100 Million Dollar Nuvaring Litigation originally commenced by Attorney Jason T. Brown have been satisfied. Organon has until August 13, 2014 to fund the settlement QSF. Jersey City, NJ (PRWEB) June 30, 2014 The terms of the Nuvaring Master Settlement Agreement have been satisfied triggering a deadline of August to fund the $100 million dollar settlement fund, according to attorney Jason T. Brown. Last week the Federal Judge in St. Louis presiding over The...

2014-06-24 08:30:22

FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) announced late last week there has been another risk linked to testosterone treatments. The FDA now requires manufacturers of testosterone or low-T products to add a general label warning about the increased risk for blood clots in veins to their prescription testosterone treatments. Blood clots in the veins, also known as venous...

2014-06-23 23:02:26

The Firm is evaluating testosterone treatment lawsuits on behalf of men who may have suffered life-threatening cardiovascular injuries, including heart attacks, strokes and blood clots, due to low testosterone therapy. New York, NY (PRWEB) June 23, 2014 As testosterone lawsuit (http://www.testosteronelawsuitclaims.com/) filings continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the Food & Drug Administration (FDA) is warning of a potential risk for venous blood clots...

FDA Orders Testosterone Supplement Makers To Include Blood Clot Warnings
2014-06-22 08:51:08

redOrbit Staff & Wire Reports – Your Universe Online The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins, various media outlets reported on Friday. While testosterone products already carry warning labels pertaining to a risk of clots associated with polycythemia, which involved an abnormal increase in red blood cells after use of such supplements, Reuters...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related